Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

21 Sep 2011 07:00

RNS Number : 5843O
Standard Life Euro Pri Eqty Tst PLC
21 September 2011
 



 

 

Standard Life European Private Equity Trust PLC

 

 

Investment update for the quarter ended 30 June 2011

 

·; NAV increased by 8.8% to 242.5p for the quarter ended 30 June 2011

·; NAV increased by 24.2% for the first nine months of the current financial year starting 1 October 2010

·; During the quarter the portfolio rose in value by £17.0 million (4.7% of NAV) on a constant exchange rate basis; in addition, unrealised foreign exchange gains on the portfolio were £6.5 million (1.8% of NAV). Realised gains and income were £10.6 million (2.9% of NAV)

·; 100% by value of the portfolio was valued by the respective underlying managers at 30 June 2011

·; Outstanding commitments were £144.5 million at 30 June 2011

·; Net indebtedness was £45.1 million at 30 June 2011

 

For the quarter ended 30 June 2011 the Company's net asset value per ordinary share ("NAV") rose by 8.8% to 242.5p (diluted - 239.4p), from 222.9p (diluted - 220.3p) at 31 March 2011. At 30 June 2011 the Company's net assets were £391.7 million (31 March 2011 - £360.1 million).

 

The European private equity market grew in Q2 2011, with the enterprise value of all transactions reported during the quarter rising to €27.3 billion, up from €13.8 billion in Q1 2011 and €14.3 billion in the equivalent Q2 in 2010. Activity was most pronounced in the mid and large market segments of the European buy-out market.

 

The closing value of the Company's portfolio of 38 private equity fund interests was £436.3 million at 30 June 2011 (31 March 2011 - £410.9 million). Total net unrealised gains for the quarter ended 30 June 2011 were £23.5 million, of which £17.0 million comprised unrealised gains on a constant exchange rate basis and £6.5 million were unrealised foreign exchange gains. The uplift in the portfolio on a constant exchange rate basis continued to reflect strong earnings growth at many underlying investee companies, against a background of broadly flat listed equity markets over the quarter.

 

The Company funded £7.4 million of draw downs (six months ended 31 March 2011 - £29.0 million) and received £16.1 million of distributions (six months ended 31 March 2011 - £36.9 million) during the quarter. The distributions received generated £10.6 million of realised gains and income, which is equivalent to a return of 2.9 times the acquisition cost of the realised investments.

 

The Company made one new private equity fund commitment during the quarter, committing €30.0 million to Montagu IV. The Company had total outstanding commitments to its private equity fund interests of £144.5 million at 30 June 2011 (31 March 2011 - £123.0 million).

 

At 30 June 2011 the Company had net indebtedness of £45.1 million (31 March 2011 - net indebtedness of £51.4 million).

 

During the period from 30 June 2011 to 20 September 2011 the Company funded £10.3 million of draw downs and received £21.4 million of distributions. At 20 September 2011 the Company's total outstanding commitments and net indebtedness were £130.3 million and £33.8 million respectively. No new fund commitments were made in the period from 30 June 2011 to 20 September 2011.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2011 on or around 5 December 2011. In preparing the valuation of the Company's private equity fund interests at 30 September 2011, the Board is mindful of the movement and volatility in listed financial markets since 30 June 2011 and the need to review in detail the valuations received from underlying managers.

 

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under section 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLFKFXBBL
Date   Source Headline
8th Oct 20185:07 pmRNSDirector/PDMR Shareholding
2nd Oct 20181:04 pmRNSQuarterly Disclosure
1st Oct 20187:00 amRNSEstimated Net Asset Value at 31 August 2018
1st Oct 20187:00 amRNSQuarterly Trading Statement
7th Sep 20187:00 amRNSDividend Declaration
30th Aug 20182:24 pmRNSDirector/PDMR Shareholding
28th Aug 20187:00 amRNSChange of Auditor
14th Aug 20187:00 amRNSEstimated Net Asset Value at 31 July 2018
8th Aug 20189:14 amRNSDirector/PDMR Shareholding
3rd Aug 20183:33 pmRNSDirector/PDMR Shareholding
17th Jul 201812:17 pmRNSUpdate research from QuotedData
13th Jul 20183:22 pmRNSEdison reviews Standard Life Private Equity Trust
13th Jul 20187:00 amRNSEstimated Net Asset Value at 30 June 2018
11th Jul 20185:32 pmRNSHolding(s) in Company
5th Jul 201811:55 amRNSDirector/PDMR Shareholding
3rd Jul 201812:43 pmRNSQuarterly Disclosure
18th Jun 20187:02 amRNSEstimated Net Asset Value at 31 May 2018
18th Jun 20187:01 amRNSDividend Declaration
18th Jun 20187:00 amRNSHalf-year Report
15th Jun 201811:50 amRNSDirectorate Change
15th May 20187:00 amRNSEstimated Net Asset Value at 30 April 2018
14th May 20183:48 pmRNSDirector/PDMR Shareholding
8th May 201812:06 pmRNSDirector/PDMR Shareholding
8th May 201812:02 pmRNSDirector/PDMR Shareholding
1st May 201812:54 pmRNSDirector/PDMR Shareholding
18th Apr 20183:24 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSEstimated Net Asset Value at 31 March 2018
4th Apr 20182:09 pmRNSQuarterly Disclosure
26th Mar 20187:00 amRNSEstimated Net Asset Value at 28 February 2018
26th Mar 20187:00 amRNSQuarterly Trading Statement
21st Mar 20187:00 amRNSDividend Declaration
16th Mar 20189:46 amRNSHolding(s) in Company
13th Mar 201810:53 amRNSHolding(s) in Company
8th Mar 201811:00 amRNSKepler Trust Intelligence Research
27th Feb 20185:22 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSEstimated Net Asset Value at 31 January 2018
9th Feb 20183:45 pmRNSDirector/PDMR Shareholding
9th Feb 20183:44 pmRNSDirector/PDMR Shareholding
7th Feb 201811:38 amRNSEdison review: Standard Life Private Equity Trust
2nd Feb 201811:29 amRNSDirector/PDMR Shareholding
31st Jan 20183:17 pmRNSDirector/PDMR Shareholding
25th Jan 20182:48 pmRNSResult of AGM
15th Jan 20187:00 amRNSEstimated Net Asset Value at 31 December 2017
3rd Jan 20182:28 pmRNSQuarterly Disclosure
3rd Jan 201810:52 amRNSDirector/PDMR Shareholding
14th Dec 20177:00 amRNSEstimated Net Asset Value at 30 November 2017
13th Dec 20173:41 pmRNSDirector/PDMR Shareholding
13th Dec 201711:26 amRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDividend Declaration
8th Dec 201711:58 amRNSUpdate research from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.